{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-063521","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.520855+00:00","generated_at":"2026-05-18T06:40:36.352724+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avalon GloboCare granted Hong Kong patent for CAR-T/CAR-NK cell technology","bullets":["Hong Kong Intellectual Property Department issued standard patent HK40074322 for CAR-T and CAR-NK cell technology.","Patent term of 20 years effective February 21, 2020, providing protection through 2040 in Hong Kong.","Co-developed with strategic partner Arbele Limited; complements existing US and PCT patent protections.","Technology features bispecific Anti-CD19xCD22 CAR design and localized cytokine induction to enhance efficacy."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-063521","json":"https://secwatch.observer/filing/0001213900-25-063521.json","markdown":"https://secwatch.observer/filing/0001213900-25-063521.md","text":"https://secwatch.observer/filing/0001213900-25-063521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025063521/0001213900-25-063521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025063521/ea0248802-8k_avalon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:40:36.352724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}